Quarterly ResultAug 4, 2026, 07:08 AM
Bruker Q2 Revenue $838.5M; Non-GAAP EPS $0.49; Updates FY26 Guidance
AI Summary
Bruker Corporation announced its second quarter 2026 financial results, reporting revenues of $838.5 million, a 5.2% increase year-over-year, with organic growth of 2.8%. The company posted a GAAP diluted loss per share of $(0.41), primarily due to $134.9 million in goodwill impairment charges, but achieved non-GAAP diluted EPS of $0.49. Bruker Scientific Instruments (BSI) saw strong organic bookings growth of 10%. The company updated its full-year 2026 guidance for currency and tax only, projecting revenues of $3.54 billion to $3.57 billion and non-GAAP EPS of $2.10 to $2.15.
Key Highlights
- Q2-26 revenue was $838.5 million, up 5.2% year-over-year (2.8% organically).
- Q2-26 GAAP diluted loss per share was $(0.41), including $134.9M goodwill impairment.
- Q2-26 non-GAAP diluted EPS was $0.49, compared to $0.32 in Q2-25.
- Bruker Scientific Instruments (BSI) bookings were up 10% organically year-over-year.
- FY2026 revenue guidance updated to $3.54B-$3.57B (3-4% YoY, 1-2% organic).
- FY2026 non-GAAP EPS guidance updated to $2.10-$2.15 (15-17% YoY growth).
Price Impact
More from BRKR